Catherine M. Szyman

Insider Reports History

Location
Irvine, CA
Signature
/s/ Micah W. Young, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine M. Szyman:

Form 4 holding CVP, Critical Care

Edwards Lifesciences Corp

Security class
Common Stock
Shares / value
81,287
Estimated value
$5,686,869
Report date
03 Sep 2024
Price
$69.96
Ownership
Direct
Form 4 holding CEO, Director

MASIMO CORP

Security class
Restricted Stock Units
Shares / value
6,306
Estimated value
$1,443,986
Report date
11 Mar 2026
Price
$171.76
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CEO, Director

MASIMO CORP

Security class
Common Stock
Shares / value
7,605
Estimated value
$1,026,979
Report date
11 Mar 2026
Price
$135.04
Ownership
Direct
Form 4 holding Director

Outset Medical, Inc.

Security class
Common Stock
Shares / value
24,596
Estimated value
$105,517
Report date
31 May 2023
Price
$4.29
Ownership
Direct
Form 4 holding CVP, Critical Care

Edwards Lifesciences Corp

Security class
Performance Rights
Shares / value
0
Estimated value
$0
Report date
04 May 2024
Price
$100.52
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Inari Medical, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
$0
Report date
19 Feb 2025
Price
$0.4569
Ownership
Direct
Form 4 holding CVP, Critical Care

Edwards Lifesciences Corp

Security class
Employee Stock Option (Right to Acquire)
Shares / value
0
Estimated value
Report date
15 Feb 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Inari Medical, Inc.

Security class
Stock Option
Shares / value
0
Estimated value
Report date
19 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Catherine M. Szyman

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .